The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain
Open accessAbstract
Objectives: To compare patients' preference for transdermal fentanyl or sustained release oral morphine, their level of pain control, and their quality of life after treatment. Design: Randomised, multicentre, international, open label, crossover trial. Setting: 35 centres in Belgium, Canada, Denmark, Finland, the United Kingdom, the Netherlands, and South Africa. Participants: 256 patients (aged 26-82 years) with chronic non-cancer pain who had been treated with opioids. Main outcome measures: Patients' preference for transdermal fentanyl or sustained release oral morphine, pain control, quality of life, and safety assessments. Results: Of 212 patients, 138 (65%) preferred transdermal fentanyl, whereas 59 (28%) preferred sustained release oral morphine and 15 (7%) expressed no preference. Better pain relief was the main reason for preference for fentanyl given by 35% of patients. More patients considered pain control as being “good” or “very good” with fentanyl than with morphine (35% v 23%, P=0.002). These results were reflected in both patients' and investigators' opinions on the global efficacy of transdermal fentanyl. Patients receiving fentanyl had on average higher quality of life scores than those receiving morphine. The incidence of adverse events was similar in both treatment groups; however, more patients experienced constipation with morphine than with fentanyl (48% v 29%, P<0.001). Overall, 41% of patients experienced mild or moderate cutaneous problems associated with wearing the transdermal fentanyl patch, and more patients withdrew because of adverse events during treatment with fentanyl than with morphine (10% v 5%). However, within the subgroup of patients naive to both fentanyl and morphine, similar numbers of patients withdrew owing to adverse effects (11% v 10%, respectively). Conclusion: Transdermal fentanyl was preferred to sustained release oral morphine by patients with chronic non-cancer pain previously treated with opioids. The main reason for preference was better pain relief, achieved with less constipation and an enhanced quality of life. What is already known on this topic: The clinical use of potent opioids in the treatment of chronic non-cancer pain is supported by retrospective, survey data and small randomised controlled trials showing efficacy and safety Studies with transdermal fentanyl have shown efficacy and preference over sustained release oral morphine in the treatment of cancer pain What this study adds: This is the first study to provide comparative data supporting treatment options with potent opioids for chronic non-cancer pain Both transdermal fentanyl and sustained release oral morphine provided effective and well tolerated pain relief During fentanyl treatment patients experienced superior pain relief, higher quality of life, and less constipation; fentanyl was preferred to morphine by 65% of patients
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · PubMed · Cited by 33,716
The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Persistent Pain and Well-being: A World Health Organization Study in Primary Care
Gureje, O., Von Korff, M., Simon, G. E., & Gater, R. (1998) · JAMA · doi:10.1001/jama.280.2.147 · Cited by 1,496
Amanzio, M., & Benedetti, F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-01-00484.1999 · Cited by 899
Efficacy of oxycodone in neuronathic pain: A randomized trial in postherpetic neuralgia
N. Watson, C. P., & Babul, N. (1998) · Neurology · doi:10.1212/wnl.50.6.1837 · Cited by 646
Moore, A. R., Gavaghan, D., Tramèr, R. M., Collins, L. S., & McQuay, J. H. (1998) · Pain · doi:10.1016/s0304-3959(98)00140-7 · Cited by 604
Opioid therapy for chronic nonmalignant pain: a review of the critical issues
Portenoy, R. K. (1996) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(95)00187-5 · Cited by 533
Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia
Rowbotham, M. C., Reisner-Keller, L. A., & Fields, H. L. (1991) · Neurology · doi:10.1212/wnl.41.7.1024 · Cited by 477
Ahmedzai, S., & Brooks, D. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(97)00082-1 · Cited by 475
Koch, G. G. (1972) · Biometrics · doi:10.2307/2556170 · Cited by 465
McQuay, H. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03528-x · Cited by 414
Can it work? Does it work? Is it worth it?
Haynes, B. (1999) · BMJ · doi:10.1136/bmj.319.7211.652 · Cited by 405
Randomised trial of oral morphine for chronic non-cancer pain
Moulin, D. E., Amireh, R., Sharpe, W. K. J., Boyd, D., Merskey, H., & Iezzi, A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90339-6 · Cited by 391
Ashburn, M. A., & Staats, P. S. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04088-x · Cited by 371
Understanding controlled trials: What is a patient preference trial?
Torgerson, D., & Sibbald, B. (1998) · BMJ · doi:10.1136/bmj.316.7128.360 · Cited by 304
Donner, B., Zenz, M., Tryba, M., & Strumpf, M. (1996) · Pain · doi:10.1016/0304-3959(95)00180-8 · Cited by 261
Jeal, W., & Benfield, P. (1997) · Drugs · doi:10.2165/00003495-199753010-00011 · Cited by 233
Payne, R., Mathias, S. D., Pasta, D. J., Wanke, L. A., Williams, R., & Mahmoud, R. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1588 · Cited by 227
Opioid tolerance: the clinical perspective
Collett, B. J. (1998) · British Journal of Anaesthesia · doi:10.1093/bja/81.1.58 · Cited by 207
Uhl, G. R., Sora, I., & Wang, Z. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.7752 · Cited by 206
Dellemijn, P. L., & Vanneste, J. A. (1997) · The Lancet · doi:10.1016/s0140-6736(96)09024-1 · Cited by 204
Persistent Pain and Well Being: a World Health Organization Study in Primary Care
GUREJE, O., VON KORFF, M., SIMON, G. E., & GATER, R. (1999) · Survey of Anesthesiology · doi:10.1097/00132586-199906000-00054 · Cited by 194
Arkinstall, W., Sandler, A., Goughnour, B., Babul, N., Harsanyi, Z., & Darke, A. C. (1995) · Pain · doi:10.1016/0304-3959(94)00262-d · Cited by 164
Involving patients in clinical research
Goodare, H., & Lockwood, S. (1999) · BMJ · doi:10.1136/bmj.319.7212.724 · Cited by 156
Prolonged Treatment with Transdermal Fentanyl in Neuropathic Pain
Dellemijn, P. L. I., van Duijn, H., & Vanneste, J. A. L. (1998) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(98)00070-0 · Cited by 141
Long-Term Treatment of Cancer Pain With Transdermal Fentanyl
Donner, B., Zenz, M. W., Strumpf, M., & Raber, M. (1998) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(97)00361-8 · Cited by 129
Treatment Principles for the Use of Opioids in Pain of Nonmalignant Origin
Schug, S. A., Merry, A., & Acland, R. H. (1991) · Drugs · doi:10.2165/00003495-199142020-00005 · Cited by 112
When placebo controlled trials are essential and equivalence trials are inadequate
Tramèr, M. R., Reynolds, D. J. M., Moore, R. A., & McQuay, H. J. (1998) · BMJ · doi:10.1136/bmj.317.7162.875 · Cited by 109
Zech, D. F. J., Grond, S., Lynch, J., Dauer, H. G., Stollenwerk, B., & Lehmann, K. A. (1992) · Pain · doi:10.1016/0304-3959(92)90034-9 · Cited by 107
Opioid sensitivity of chronic pain: a patient‐controlled analgesia method
McQuay, H. J., Jadad, A. R., Carroll, D., Faura, C. C., Glynn, C. J., Moore, R. A., & LIU, Y. (1992) · Anaesthesia · doi:10.1111/j.1365-2044.1992.tb03253.x · Cited by 92
Thomas, V. N. (1997) · International Journal of Nursing Studies · doi:10.1016/s0020-7489(97)84430-6 · Cited by 74
The use of oral opioids in patients witt chronic non‐cancer pain
Graziotti, P. J., & Goucke, R. C. (1997) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1997.tb138760.x · Cited by 65
Transdermal fentanyl in cancer pain
Ahmedzai, S. H., Allen, E. A., & Fallon, M. (1994) · Cited by 53
Chronic opioid analgesic therapy for chronic low back pain.
Brown, R. L., Fleming, M. F., & Patterson, J. J. (1996) · PubMed · Cited by 39
Cited by
Pergolizzi, J., Böger, R. H., Budd, K., Dahan, A., Erdine, S., Hans, G., Kress, H., Langford, R., Likar, R., Raffa, R. B., et al. (2008) · Pain Practice · doi:10.1111/j.1533-2500.2008.00204.x · Cited by 854
Opioid-Induced Bowel Dysfunction: Pathophysiology and Potential New Therapies
Kurz, A., & Sessler, D. I. (2003) · Drugs · doi:10.2165/00003495-200363070-00003 · Cited by 587
Fishbain, D. A., Cole, B., Lewis, J., Rosomoff, H. L., & Rosomoff, R. S. (2008) · Pain Medicine · doi:10.1111/j.1526-4637.2007.00370.x · Cited by 565
Predictors of opioid misuse in patients with chronic pain: a prospective cohort study
Ives, T. J., Chelminski, P. R., Hammett-Stabler, C. A., Malone, R. M., Perhac, J. S., Potisek, N. M., Shilliday, B. B., DeWalt, D. A., & Pignone, M. P. (2006) · BMC Health Services Research · doi:10.1186/1472-6963-6-46 · Cited by 519
Manchikanti, L. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s5 · Cited by 436
Metadata
- Authors
- Allan, L., Hays, H., Jensen, N.-H., de Waroux, B. L. P., Bolt, M., Donald, R., & Kalso, E.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2001-05-12
- Volume
- 322
- Issue
- 7295
- Pages
- 1154
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2117950925
- Cited by
- 305
- References
- 35
- FWCI
- 21.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.